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Background. We quantified the relationship between human immunodeficiency virus (HIV) RNA shedding in
breast milk, cumulative RNA exposure, and postnatal transmission, relating timing of infection in the infant to
estimated total volume of milk exposure.
Methods. Nested case-control study of 36 infants of HIV-infected mothers. Case patients were infants who
acquired HIV infection through breastfeeding from age 6 through 28 weeks, and control subjects were uninfected
infants matched on age at obtainment of a breast milk sample. Mothers and infants received peripartum single-dose
nevirapine prophylaxis. Feeding data were collected daily; breast milk samples were collected and infant
anthropometry was performed at 6 weeks and monthly thereafter. Volume of milk ingested was estimated using
infant weight and feeding pattern.
Results. Before HIV acquisition in case patients, feeding pattern (exclusive breastfeeding; median duration, 65
vs 70 days; P5 .6) and daily milk intake (mean volume, 638 vs 637 mL; P5 .97) did not differ significantly between
case patients and control subjects. Case mothers were more likely to shed virus (64% vs 9% always, 22% vs 20.5%
intermittently, 14% vs 70.5% never shed; overall, P , .001). Case patients ingested 15 times more HIV-1 RNA
particles than did control subjects (196.5 vs 13 3 106 copies; P , .001). Allowing for maternal antenatal CD4 cell
count and plasma HIV-1 load, child sex and duration of mixed breastfeeding, the association between HIV RNA
exposure and infection remained statistically significant (P , .001).
Conclusions. Postnatal acquisition of HIV-1 is more strongly associated with cumulative exposure to cell-free
particles in breast milk than with feeding mode. Reducing breast milk viral load through antiretroviral therapy to
mother or child can further decrease postnatal transmission in exclusively breastfed infants.
The 2009 World Health Organization infant feeding
recommendations for human immunodeficiency virus
(HIV)–infected mothers in settings where replacement
feeding is neither safe nor affordable are to breastfeed
the infant for the first year, with antiretroviral treatment
and/or prophylaxis for mothers or their infants [1]. This
advice aims to reduce the risk of mother-to-child
transmission of HIV through breastfeeding, which is
estimated to be 4% during the first 6 months of exclu-
sive breastfeeding and 1% per additional month of
breastfeeding thereafter [2–5]. It has previously been
estimated that the risk of acquisition of infection
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through breast milk is .00064 per liter of breast milk ingested
[6]. However, this estimate does not account for breastmilk viral
load, the intermittent nature of virus RNA shedding in milk, and
the intensity of breastfeeding [7]. Three major HIV reservoirs
coexist in breast milk: RNA, which represents cell-free viral
particles; proviral DNA as cell-associated virus integrated in
latent T cells; and intracellular RNA representing cell-associated
virus in activated producing T cells [8–13]. Their respective role
in breast milk transmission of HIV-1 is poorly understood.
Because of the low estimated probability of transmission
through breast milk per liter of milk ingested and the in-
termittent pattern of cell-free virus shedding in milk, postnatal
HIV transmission through breastfeeding likely depends on the
cumulative HIV exposure (ie, the overall amount of cell-free and
cell-associated viral particles ingested by the infant during
breastfeeding) and pattern or intensity of feeding [exclusive vs
mixed or partial] and possibly by factors other than HIV. We
aimed to quantify the relationship between cell-free HIV shed-
ding in breast milk, cumulative cell-free HIV exposure, and
postnatal acquisition of infection at age 6–28 weeks.
METHODS
We nested a case-control study in a large infant feeding in-
tervention cohort (Vertical Transmission Study) of women at-
tending 9 clinics (8 rural and 1 urban) in KwaZulu-Natal, South
Africa, which aimed to examine breastfeeding and HIV trans-
mission in a community with a high prevalence of HIV infection
[2, 14]. Single-dose nevirapine was provided to all HIV-1–in-
fected women and their infants peripartum; women were
counselled antenatally on infant feeding options in accordance
with policy recommendations at the time: commercial formula
feeds or exclusive breastfeeding for the first 6 months of life.
Women were supported in their feeding choice by lay-workers
who visited breastfeeding mothers at home. Maternal socio-
economic level was defined by education level and household
water type [2]. Venous samples were taken from women at
enrollment and at 6 months after delivery, for plasma RNA load
assessment and CD4 cell count. Daily infant feeding data were
collected at weekly home visits. Infant weight was collected at
birth. Breast milk samples and dried blood spot samples from
infants were collected and anthropometry was performed at 6
weeks and monthly thereafter; an additional dried blood spot
sample was taken from infants after delivery [14, 15].
Postnatal transmission was defined as HIV infection acquired
at age 6–28 weeks. The estimated age at HIV-1 infection was
taken as the midpoint between the last negative RNA polymerase
chain reaction (PCR) result and the first positive RNA PCR
result [2]. Case patients were postnatally infected infants [2, 14];
42 infants received a diagnosis of HIV infection at age 49.5–197
days. Control subjects were HIV-uninfected infants matched for
infant age at the time of obtainment of breast milk samples that
was closest to a case patient’s age at first positive PCR result and
last negative PCR result (in a 1:1 ratio).
Breast milk lactoserum, including the lipid fraction, was
collected from stored (280C) whole breast milk samples.
RNA was isolated from 500 lL of lactoserum with use of the
magnetic particle-based ASPS method (Abbott), and HIV
load was quantified using the HIV Charge Virale assay
(Biocentric) on the MJ MiniOpticon quantitative PCR
detection platform (Biorad), with a sensitivity of 375 copies
per mL of lactoserum [16]. This method enabled accurate
assessment of cell-free viral load that is preferentially
entrapped by lipids [17]. Feeding categories followed World
Health Organization definitions [2, 14, 15].
The Vertical Transmission Study and breast milk analyses
were approved by the Biomedical Research Ethics Committee of
the University of KwaZulu-Natal.
Statistical Methods
Case-control pairs with information on feeding pattern, infant
weight, and breast milk viral load were included in the present
analysis. Duration of breastfeeding was estimated using the
Kaplan-Meier method and was compared between case patients
and control subjects with use of the log-rank test. Half the value
of the threshold (375/2 copies/mL of lactoserum; 50/2 copies/
mL of plasma) was assigned to samples with undetectable HIV
RNA load for the purpose of logarithmic transformation. Viral
shedding in breast milk was categorized as never, intermittent,
and permanent shedders [18].
The volume of milk ingested per day was estimated according
to Arcus-Arth [19] as (2.312*age1157.7*weight) in exclusively
breastfed infants, with a multiplicative correction factor when,
in addition to breast milk, the infant was given water (1), for-
mula (.7), solids (.9), or at least 2 other foods (.7) [20]. Monthly
weight measurements were linearly interpolated to obtain
daily weight. In 3 control subjects and 1 case patient, missing
birth weights were replaced by the median birth weight observed
in the overall cohort (3100 g) [2]. The probability of trans-
mission per liter of breast milk ingested was computed using
estimated milk volume ingested and estimated risk of postnatal
transmission through breastfeeding in the Vertical Transmission
Study cohort [2]. Daily HIV RNA exposure (ie, the amount of
cell-free viral particles in the volume of milk ingested) was equal
to the product of linearly interpolated milk HIV RNA load and
daily milk intake. By assuming that there was no predominant
breast, mean daily HIV RNA exposure between breasts could be
estimated. Cumulative HIV RNA exposure was estimated as the
sum of daily RNA exposure between the first breast milk sample
at 6 weeks and HIV acquisition, with left and right truncating
to elicit summation over the same period in each case-control
pair. For each woman, the slope of HIV RNA load between the
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last negative HIV PCR result and the first positive test result was
computed as the ratio of HIV RNA load variation over the time
between the 2 PCR tests.
Associations between parameters with non-Gaussian dis-
tributions were assessed using the Spearman correlation co-
efficient. TheWilcoxon signed-rank test for paired data was used
to compare HIV RNA exposure and RNA load between case
patients and their matched control subjects and between right
and left breasts. To estimate the risk of postnatal transmission
associated with cumulative HIV exposure in breast milk, we built
a conditional logistic regression model with use of the PHREG
procedure in SAS, version 9.1 (SAS Institute). Variables shown
to be associated with postnatal transmission on the basis of
a P value ,.2 in univariate analysis were included in the mul-
tivariable model, after verifying the absence of multicollinearity.
All analyses were performed using SAS version 9.1 (SAS In-
stitute).
RESULTS
Of 42 case-control pairs, 6 were excluded from further analyses
because only 1 breast milk sample was available (5 pairs) or
feeding data were collected after the estimated age of HIV ac-
quisition (1 pair). In the remaining 36 pairs, the median esti-
mated infant age at HIV acquisition was 89.5 days (interquartile
range [IQR], 66–128 days; range, 49.5–186.5 days), with a last
negative PCR test result at a minimum of 39 days; the median
duration between the last negative and the first positive PCR test
results was 28 days (IQR, 28–43 days). Case patients were mostly
male, with a nonsignificantly higher birth weight, significantly
higher maternal socioeconomic status, significantly lower ma-
ternal antepartum and postpartum CD4 cell count, and higher
antepartum plasma RNA load (Table 1). Breast health problems,
particularly serious breast pathologies, were rare (2 mothers of
case patients) [21].
Table 1. Maternal and Infant Characteristics of HIV-1–Infected Infants and HIV-1–Uninfected Infantsa
HIV-1–infected infants HIV-1–uninfected infants
No. No. P value
Maternal characteristic
Age at delivery, years 36 25.1 (22–28.2) 36 26.4 (20.0–30.8) .88
Enrolment clinic, no. (%) .77
Urban 9 (25) 8 (22.2)
Semi-urban 13 (36.1) 11 (30.6)
Rural 14 (38.9) 17 (47.2)
Highest level of education, no. (%) .59
No education 2 (5.6) 3 (8.3)
Some primary 9 (25) 13 (36.1)
Secondary and tertiary 24 (66.7) 20 (55.6)
Unknown 1 (2.8)
Water type, no. (%) .06
Borehole, tank, well 1 (2.8) 3 (8.3)
River, stream 8 (22.2) 14 (38.9)
Piped water 27 (75) 17 (47.2)
Other 2 (5.6)
Previous liveborns, no. (range) 35 0 (0–2) 36 1 (0–2) .07
Mode of delivery, no. (%) .71
Vaginal 31 (86) 33 (92)
Caesarean 5 (14) 3 (8)
Duration of rupture of membranes, h 24 0.25 (.1–9.5) 31 0.5 (.1–5) .83
Antenatal CD4 cell count, cells/lL 34 369 (223–558) 35 519 (443–600) .037
Antenatal plasma HIV-1 RNA load, log10 copies/mL 32 4.38 (4.02–4.90) 34 4.00 (2.99–4.82) .02
CD4 cell count at 6 months postpartum, cells/lL 28 376 (224–666) 36 623 (417–703) .01
Plasma HIV-1 RNA load at 6 months post-partum, log10 copies/mL 27 4.45 (3.88–4.92) 30 4.06 (3.08–4.65) .095
Infant characteristics
Sex male, no. (%) 22 (61) 15 (42) .098
Birth weight, g 35 3200 (2800–3500) 33 3000 (2650–3300) .37
Age at last HIV negative test result (day) 36 68 (44–116) 36 458 (410–548)
Age at first HIV positive test result (day) 36 115 (88–154) Not applicable
a median (inter-quartile) are reported for quantitative variables
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Breastfeeding Pattern
Overall, during the first 28 weeks of life, data on the breast-
feeding pattern was collected up to 200 days for control subjects
and for a slightly shorter period for case patients (median, 200
days; IQR, 198–200 days). Control subjects were exclusively
breastfed for longer than case patients (median duration, 183 vs.
157 days; P 5 .003), although the overall duration of any
breastfeeding was not significantly different between the 2
groups (P 5 .17). Before the age at HIV acquisition in the case
patients (and matched age in the control subjects), cumulative
feeding patterns did not differ significantly: 20 case patients
(69%) and 25 control subjects (76%) were exclusively breastfed
from birth (P 5 .55). The median duration of exclusive
breastfeeding before HIV acquisition was 65 days (IQR, 51–95
days) for case patients and 70 days (IQR, 53–107) for control
subjects (P5 .6), with again nonsignificant difference in median
duration of any breastfeeding for both case patients and control
subjects (90 days; IQR, 67–128 days).
Milk Intake and Risk of Postnatal Transmission through Breast
Milk
The estimated milk volume ingested at age 6–28 weeks (Figure
1A) or before HIV acquisition (Figure 1B) did not differ sig-
nificantly between case patients and control subjects, with
a mean daily milk intake of 638 mL in case patients and 637 mL
in control subjects (P 5 .97).
The estimated risk of postnatal transmission through
breastfeeding in this study was previously estimated at .032 per
100 child-days (95% confidence interval [CI], .0222–.0455 per
100 child-days)[2], which translates to an estimated probability
of .0005 (95% CI, .00035–.00071) per liter of breast milk in-
gested.
HIV Shedding in Breast Milk in the First 6 Months of Life
From 34 days through 28 weeks postpartum, there were a total
of 318 samples from both breasts taken at the same visit; median
number of breastmilk samples per woman was 5 in case mothers
(range, 2–6) and 4 in control mothers (range, 3–5). The mean
breast milk HIVRNA load over the first 28 weeks per mother was
inversely correlated with maternal antepartum CD4 cell count
(q 5 2.47; 95% CI, 2.63 to 2.26; n 5 69) and positively with
maternal plasma HIV RNA level before (q 5 .46; 95% CI, .24–
.63; n5 66) or 6 months after delivery (Appendix Tables A1 and
A2, Figures A1 A and B).
Undetectable HIV RNA in milk was quasi-uniformly dis-
tributed over time (Appendix Figures A2 A and B), and there
was no statistically significant variation in viral load slope (mean
difference,2.0001; n5 33 in right breast;2.0000; n5 34 in left
Figure 1. A, Daily milk volume before 28 weeks of age in HIV-infected infants (case patients) and in uninfected infants (control subjects). B, Daily milk
volume before HIV acquisition in HIV-1–infected infants (case patients) and in uninfected infants (control subjects).
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breast). Comparing left and right breast, breast milk HIV-1 RNA
load was always at least .3 log10 copies/mL higher in the left
breast in 2 case mothers (3%), intermittently higher in 1 breast
in 44 (61%) mothers (33 case patient and 11 control subjects),
and always similar in both breasts (difference,, .3 log10 copies/
mL) in 26mothers (36%; 1 case patient and 25 control subjects).
Breast milk viral load did not vary statistically significantly be-
tween breasts (mean difference, 2.04 log10 copies/mL; P 5 .29;
n 5 318), and loads in breasts per woman were strongly cor-
related (q5 .61; 95%CI, .54–.68). Further analysis assumed that
there was no predominant breast.
By 28 weeks postpartum, mothers of case patients were more
likely to shed virus from either breast than were mothers of
control subjects (44% vs 3% always, 53% vs 35% intermittently,
and 3% vs 62% never shed; overall P , .001).
Accounting for episodes with detectable breast milk viral load,
either for all or only for those before HIV acquisition in case
patients, the mean HIV RNA load was significantly higher in
breast milk of case mothers (Table 2).
Cumulative Cell-Free HIV Exposure Through Breast Milk Before
HIV Acquisition
Cumulative HIV RNA exposure was estimated from a me-
dian age of 44.5 days (range, 38–68 days) for a median du-
ration of 41 days IQR, 22–72 days). Infants ingested
a median estimated amount of 231,325 free HIV particles
daily IQR, 138,439–1,416,627 particles; case patients: me-
dian, 1,349,530; IQR, 341,400–4,328,963; control subjects:
median, 142,118; IQR, 125,116–179,289). We estimated that
case patients ingested 15 times more cell-free HIV RNA
particles than did control subjects (196.5 3 106 vs 13.0 3 106;
P, .001). To investigate whether the association remained after
allowing for maternal disease progression, we analyzed the 12
case-control pairs in which both members had a maternal
postpartum CD4 cell count .350 cells/lL. In this comparison,
infected infants were still estimated to have been exposed to
significantly more cell-free HIV particles than control subjects
(22.4 3 106 vs. 8.05 3 106; P , .001) before HIV acquisition;
maternal antepartum CD4 cell count (median, 518 vs 510 cells/
lL; P5 .66), and maternal antepartum plasma HIV-1 RNA load
(median, 3.98 vs 4.04 log10 copies/mL; P 5 .56) did not differ
significantly between case patients and control subjects in these
pairs. After adjustment for infant sex, maternal antepartum CD4
cell count, maternal antepartum plasma viral load, and duration
of mixed breastfeeding, a 1 3 107 increase in HIV-1 RNA in-
gested particles was associated with a 2-fold increased risk of
postnatal infection in the infant (adjusted odds ratio, 2.06;
95%CI, 1.02–4.16) (Table 3).
DISCUSSION
We estimated the number of HIV cell-free particles in breast
milk ingested by an infant before acquiring infection and
showed that infants who became postnatally infected at 6–28
weeks of age ingested significantly more cell-free viral particles
from breast milk than did uninfected infants, independently of
maternal HIV CD4 cell count and plasma viral load. Because the
estimated volume of breast milk consumed did not significantly
differ between case patients and control subjects, the difference
in exposure of the virus particles was driven by increased HIV
shedding in breast milk from mothers of case patients. Our
estimated probability of breast milk transmission (.0005 per liter
ingested) was of the same order of magnitude as a previous
estimate reported from a Kenyan study (.00064 per liter in-
gested) [6].
Our stusy was a case-control study nested in a well-designed
prospective cohort, with intensive infant feeding support and
follow-up and high-quality longitudinal data [2, 14, 22].
Mothers and infants were given single-dose nevirapine pro-
phylaxis at or shortly after delivery only. Most importantly, the
daily collected breastfeeding information, monthly collected
maternal and child clinical data, infant HIV status, and breast
milk samples from both breasts allowed the estimation of
quantity of virus shedding in the breast milk, volume of milk
intake, HIV RNA exposure, and assessment of the association of
these factors with postnatal transmission. In addition,
Table 2. Median HIV RNA Load in Breast Milk in Episodes with Detectable HIV RNA








log10 copies/mL (IQR) P
Before HIV-1 acquisition
Right breast 45 3.37 (3.13–3.82) 6 2.93 (2.72–3.08) 0.005
Left breast 43 3.45 (3.07–4.02) 9 3.06 (2.83–3.28) .045
Before 28 weeks
Right breast 98 3.32 (3.05–3.75) 12 2.99 (2.74–3.15) .001
Left breast 103 3.43 (2.98–4.01) 16 3.06 (2.91–3.51) .09
Abbreviations: IQR, interquartile range.
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comparison between the 2 breasts and adjustment on con-
founding factors was also possible.
However, our study presents some limitations. We used the
midpoint between the last negative and the first positive HIV
PCR test results to estimate timing of acquisition of postnatal
infection. This assumption may underestimate variance [23];
however, because the length of the interval (median, 28 days)
was relatively short, compared with the 22-weeks duration of
follow-up, the potential bias is unlikely to be substantial. Fur-
thermore, we estimated daily milk intake using a formula based
on infant weight and feeding pattern that was validated with
healthy, full-term European or northern American infants [19].
We used correction factors based on a survey conducted in
Brazil [20] to account for introduction of food other than breast
milk. Although our cohort differs from these populations, our
daily milk intake estimates are close to age-specific standards
(658 mL vs standard 670 mL from day 8 through month 2, and
788 mL vs standard 750 mL from month 3 through month 5
[24]). The plateau in estimated volume of breast milk intake that
we observed from 8 weeks postpartum is similar to that reported
in previous studies in which investigators directly estimatedmilk
volumes by weighing infants before and after each feed [25].
Finally, although it has been suggested that subclinical mastitis
may be associated with higher breast milk viral load [9, 26], with
the intensive breastfeeding counseling, episodes of clinical and
subclinical mastitis were rare [21].
We confirm a strong correlation in breast milk HIVRNA load
between breasts [27], and although we show differential shed-
ding profiles between breasts, there seldom was a persistently
predominant breast throughout lactation, suggesting that breast
milk samples may be collected from either breast for studies
investigating HIV shedding patterns in breast milk. We also
confirm the correlation between breast milk and maternal
plasma HIV RNA loads, with lower values in breast milk, and
an inverse correlation with maternal antepartum CD4 cell
count [10].
Intermittent HIV RNA shedding was common, supporting
the need for frequent breast milk sampling to identify un-
derlying mechanisms of shedding. Mothers of case patients were
more likely to shed virus and at higher levels than were mothers
of control subjects, which confirms breast milk HIV RNA load
as a strong predictor of postnatal HIV-1 transmission [9]. There
was no significant variation in HIV RNA load in breastmilk
slope between the last negative and the first positive HIV PCR
test result in case infants of mothers, which suggests that
transmission is not explained by an abrupt increase of HIV RNA
load and favors cumulative HIV exposure as important pre-
dictor of transmission.
Mechanisms of HIV breast milk transmission remain poorly
understood. Because of the dynamic nature of the relationship
between the source of HIV reservoirs (breast milk) and the
potential target host (the maturing gastrointestinal tract of the
young infant), multiple mechanisms are likely to be at stake. A
remaining question relates to the nature of HIV reservoirs in
milk involved in transmission, and the association of HIV RNA
exposure per se with postnatal transmission does not necessarily
prove causation between the 2 events. Breast milk cellular res-
ervoirs are likely to play a major role in transmission [28]. Both
B and T lymphocytes in breast milk harbor homing markers
strongly suggesting migration from mucosal sites, particularly
from the gut [11, 29]. Recent studies identified latently infected
CD4 T cells [13] and spontaneously activated CD4 T cells [12] in
breast milk as likely reservoirs involved in transmission. These 2
reservoirs are unaffected by maternal antiretroviral therapy [12,
13, 30] and are likely responsible for residual transmission from
antiretroviral-treated lactating women. In the present study, one
transmitting mother never shed HIV-1 in breast milk, despite
multiple measurements, which confirms that at least some
breast milk transmission is attributable to cell-associated HIV
reservoirs [8, 10].
In conclusion, higher cumulative exposure to cell-free HIV
RNA in breast milk is associated with higher rates of postnatal
infection in the infant, independent of maternal CD4 cell count
and plasma viral load; cumulative exposure is attributable to
viral shedding in, rather than volume of, breast milk consumed.
The contribution of exposure to cell-associated HIV remains to
be determined, as do factors associated with compartmentalized
shedding of HIV in breast milk.
Table 3. Risk of Postnatal HIV Infection Associated with Cumulative HIV RNA Exposure in Breast Milk Between 6 Weeks of Age and
Estimated Age of HIV Infection
Variable Adjusted OR 95% CI P
Cumulative HIV-1 RNA exposure in milk (for each additional 107 copies) 2.06 1.02–4.16 .04
Maternal antepartum CD4 cell count (for each additional 100 cells/lL) 1.20 0.80–1.81 .37
Maternal antepartum plasma HIV load (for each additional log10 copies/mL) 1.05 0.45–2.46 .92
Duration of mixed breastfeeding (for each additional week) 1.04 0.94–1.15 .43
Male infants compared to female infants 3.40 0.44–26.40 .24
NOTE. The estimated age at mother-to-child HIV-1 transmission was taken as the midpoint between the last negative RNA PCR and the first positive RNA PCR
tests. Estimated by conditional logistic regression with adjustment on the other factors reported in the table.
Abbreviations: CI, confidence interval; OR, odds ratio.
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